Nasal Lotion Spray Market Growth Accelerated by Increasing Cases of Nasal Congestion
Nasal Lotion Spray Market Growth Accelerated by Increasing Cases of Nasal Congestion
The increasing prevalence of nasal congestion and other respiratory illnesses have been a major driver for the nasal lotion spray market.

Nasal lotion sprays provide relief from nasal congestion by moisturizing and lubricating the nasal cavity. They contain substances such as saline which have anti-inflammatory properties reducing nasal inflammation and discomfort associated with nasal allergies or the common cold. The Global Nasal Lotion Spray Market Size is estimated to be valued at US$ 3.5 billion in 2023 and is expected to exhibit a CAGR of 12% over the forecast period 2023-2027, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The increasing prevalence of nasal congestion and other respiratory illnesses have been a major driver for the nasal lotion spray market. According to the World Health Organization, there are over 1 billion cases of common cold reported annually. Nasal congestion is one of the most common symptoms of the cold which can cause disruption in daily activities. Nasal lotion sprays are a convenient over-the-counter option to relieve nasal congestion symptoms. Their growing uptake can be attributed to factors such as rising health awareness, increased discretionary incomes in developing countries allowing greater affordability of OTC medications.

Segment Analysis
The global nasal lotion spray market is segmented by type, container, application and distribution channel. By type, the market is dominated by chronic and acute rhinitis segment due to high prevalence of rhinitis. Chronic rhinitis includes allergic and non-allergic rhinitis which affects over 20% of population worldwide. It is long-term and persistent condition thereby increasing consumption of nasal lotion spray for relief.

Key Takeaways
The global nasal lotion spray market is expected to witness high growth.

Regional analysis shows North America hold dominant share because of advanced healthcare infrastructure and supportive reimbursement policies. Europe is the second largest market and is projected to witness steady growth owing to increasing pollution levels exacerbating respiratory diseases.

Key players operating in the nasal lotion spray market are Neil Med Pharmaceuticals, Bayer Group, GlaxoSmithKline, Becton Dickinson and Company, Pfizer, Johnson and Johnson, Advance History, Ayr Saline and Urgo. Neil Med Pharmaceuticals holds over 30% market share due to its extensive product portfolio of saline nasal sprays. GlaxoSmithKline focuses on expanding geographical presence in Asia Pacific to strengthen market position.

 

Get More Insights Here: https://www.newswirestats.com/nasal-lotion-spray-market-demand-growth-and-regional-outlook-by-2030/

disclaimer

What's your reaction?

Comments

https://www.timessquarereporter.com/assets/images/user-avatar-s.jpg

0 comment

Write the first comment for this!

Facebook Conversations